Vanderbilt University Medical Center has been selected as one of three sites to share a three-year, $1.3 million grant from the National Institutes of Health (NIH) to explore the potential therapeutic properties of manganese, a chemical element and biologically essential trace mineral, in treating Restless Legs Syndrome (RLS).

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat.

Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease.

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.

Vanderbilt investigators have used two types of neuroimaging to establish a “map” of connections for a brain region important in anxiety and addiction.

A multidisciplinary team of microbiome researchers at Vanderbilt University is shedding light on necrotizing enterocolitis (NEC), a disease of prematurity that kills hundreds of babies and costs the U.S. health care system an estimated $5 billion a year.

Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ).